Гиппократ не рад. Путеводитель в мире медицинских исследований

12. Traditional Chinese Medicine: In Depth | NCCIH. Available at: https://nccih.nih.gov/health/whatiscam/chinesemed.htm. (Accessed: 7th September 2018)

13. Федеральный закон от 21.11.2011 № 323-ФЗ. Статья 71. Клятва врача. Available at: http://www.consultant.ru/document/cons_doc_LAW_121895/7f8181673a3d85e7a31b0c55b949fa3da8974b5b/. (Accessed: 7th September 2018)

14. Nutton, V. Ancient medicine.

15. Wallis, F. Medieval medicine : a reader.

16. Debunking a myth – Harvard Gazette. Available at: https://news.harvard.edu/gazette/story/2011/04/debunking-a-myth/. (Accessed: 7th September 2018)

17. Ghannaee Arani, M. et al. Ibn Sina’s (Avicenna) Contributions in the Treatment of Traumatic Injuries. Trauma Mon. 17, 301–4 (2012).

18. Moosavi, J. The place of Avicenna in the history of medicine. Avicenna J. Med. Biotechnol. 1, 3–8 (2009).

19. Madigan, M. T. & Martinko, J. Brock Biology of Micro-Organisms Brock Biology of Microorganisms. (1997).

20. Vargesson, N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res. C. Embryo Today 105, 140–56 (2015).

21. Stephens, T. D., Bunde, C. J. & Fillmore, B. J. Mechanism of action in thalidomide teratogenesis. Biochem. Pharmacol. 59, 1489–99 (2000).

22. Merker, H. J., Heger, W., Sames, K., Stürje, H. & Neubert, D. Embryotoxic effects of thalidomide-derivatives in the non-human primate Callithrix jacchus. I. Effects of 3-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-dioxopiperidine (EM12) on skeletal development. Arch. Toxicol. 61, 165–79 (1988).

23. Latif, T., Chauhan, N., Khan, R., Moran, A. & Usmani, S. Z. Thalidomide and its analogues in the treatment of Multiple Myeloma. Exp. Hematol. Oncol. 1, 27 (2012).

24. Rehman, W., Arfons, L. M. & Lazarus, H. M. The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development. Ther. Adv. Hematol. 2, 291–308 (2011).

25. Ecklund, E. H., Johnson, D. R., Scheitle, C. P., Matthews, K. R. W. & Lewis, S. W. Religion among Scientists in International Context. Socius Sociol. Res. a Dyn. World 2, 237802311666435 (2016).

26. Scientists and Belief | Pew Research Center. Available at: http://www.pewforum.org/2009/11/05/scientists-and-belief/#fn-12952-1. (Accessed: 10th November 2018)

27. Принципы надлежащей лабораторной практики. (Стандартинформ, 2015).

28. ГОСТ Р 52249-2009 Правила производства и контроля качества лекарственных средств. Available at: http://www.vashdom.ru/gost/52249-2009/. (Accessed: 1st November 2018)

29. Willingham, E. Of lice and men: An itchy history. Scientific American (2011).

30. Han, H. et al. Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: A meta-analysis. Gene 526, 134–141 (2013).

31. WHO | Breast cancer: prevention and control. WHO (2016).

32. Широкова И. & Прожерина Ю. Рак молочной железы: взгляд экспертов. Ремедиум. Журнал о российском рынке лекарств и медицинской технике (2016).

33. Демография::Федеральная служба государственной статистики. Available at: http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/demography/#. (Accessed: 11th November 2019)

34. Клинические рекомендации РООМ. Available at: http://breastcancersociety.ru/rek/view/201. (Accessed: 11th November 2018)

35. Oeffinger, K. C. et al. Breast Cancer Screening for Women at Average Risk. JAMA 314, 1599 (2015).

36. Breast Cancer in Young Women. Available at: https://www.webmd.com/breast-cancer/breast-cancer-young-women#1. (Accessed: 11th November 2018)

37. Ferzoco, R. M. & Ruddy, K. J. The Epidemiology of Male Breast Cancer. Curr. Oncol. Rep. 18, 1 (2016).

38. Controversies in Mammography Screening. Available at: https://www.medscape.com/viewarticle/430076. (Accessed: 11th November 2018)

39. Mammograms: Benefits and Risks. Available at: https://www.breastcancer.org/symptoms/testing/types/mammograms/benefits_risks. (Accessed: 11th November 2018)

40. Bashir, M. N. Epidemiology of Prostate Cancer. Asian Pac. J. Cancer Prev. 16, 5137–41 (2015).

41. Tsodikov, A. et al. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials. Ann. Intern. Med. 167, 449 (2017).

42. Prostate Cancer Screening Guidelines | Memorial Sloan Kettering Cancer Center. Available at: https://www.mskcc.org/cancer-care/types/prostate/screening/screening-guidelines-prostate. (Accessed: 12th November 2018)

43. Общероссийский союз общественных объединений. Ассоциация онкологов России. Клинические рекомендации по диагностике и лечению рака предстательной железы. (2014).